OCULUS INNOVATIVE SCIENCES I's ticker is OCLS and the CUSIP is 67575P306. A total of 18 filers reported holding OCULUS INNOVATIVE SCIENCES I in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BARD ASSOCIATES INC | 115,424 | $501,000 | 0.24% |
| BlackRock Fund Advisors | 1,009 | $4,000 | 0.00% |
| Allworth Financial LP | 62 | $0 | 0.00% |
| VANGUARD GROUP INC | 108,042 | $468,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 128 | $0 | 0.00% |
| UBS Group AG | 4,170 | $18,000 | 0.00% |
| Wealthspire Advisors, L.P. | 128 | $1,000 | 0.00% |
| Advisor Group, Inc. | 985 | $4,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,014 | $4,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 13,437 | $58,000 | 0.00% |